36, avenue de l'Europe
Immeuble l'Etendard
Vélizy-Villacoublay 78140
France
33 1 39 45 64 50
https://www.carmatsa.com
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 177
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Stephane Piat | CEO & Director | 834,94k | N/A | 1971 |
Ms. Pascale d'Arbonneau | CFO & Head of investor relations | N/A | N/A | N/A |
Ms. Raouia Bouyanzer | Human Resources Director | N/A | N/A | N/A |
Dr. Petrus Jansen | Chief Medical Officer | N/A | N/A | N/A |
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SAs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.